Torrent Pharma Dividend Record Date on February 18: Dividend to be Paid by March 06

Torrent Pharma Ltd has decided to pay an interim dividend of ₹29 by March 06, 2026, for which the company set February 19, 2026, as the record date to mark the eligibility criteria.

Torrent Pharma said in an exchange filing, “The Board of Directors declared an interim dividend of ₹ 29/- (580 %) per equity share of ₹ 5/- fully paid up. The dividend is expected to be paid / dispatched on or around 6th March 2026.” 

Can You Buy Torrent Pharma Shares Today for Dividend Eligibility?

Torrent Pharma has announced February 19 as the record date for its interim dividend. This means that February 16 is the last day to purchase Torrent Pharma shares to be eligible for the dividend. Shares bought on or after the record date will not qualify for the interim dividend due to the T+1 settlement rule and market holidays.

Also Read: PSU Dividend Stocks to Watch: Coal India, HAL, and More Record Date is Tomorrow, Feb 18

Torrent Pharma Q3FY26 Earnings Highlights

Torrent Pharmaceuticals Limited today released its financial results for the third quarter of FY26, reflecting strong growth across key metrics. The company reported revenue of ₹3,303 crores, marking an 18% year-on-year increase. Operating EBITDA stood at ₹1,088 crores, up 19% compared to the same period last year, with an operating EBITDA margin of 33% and a robust gross margin of 76%. Net profit after tax rose 26% year-on-year, reaching ₹635 crores, underscoring the company’s solid operational performance and sustained profitability.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.